Morgan Stanley upgrades Moelis stock rating on record deal pipeline

Morgan Stanley upgraded Moelis (MC) to Overweight with a $68 price target, citing a record deal pipeline that is not contingent on interest rate cuts, robust revenue growth, and projected significant earnings per share increases stemming from an improving compensation ratio. The firm's strategic expansion into Private Funds Advisory, particularly continuation funds, is also expected to fuel long-term revenue growth. This positive outlook is further supported by strong Q1 2025 revenues and a planned leadership transition to Navid Mahmoodzadegan, signaling a clear strategic direction for the investment bank.

Analysis

Morgan Stanley's upgrade of Moelis (MC) to Overweight with a significant price target increase to $68.00 from $42.00 is underpinned by several key positive catalysts. The primary driver is management's disclosure of a record-level deal pipeline that has increased since April and, critically, is not contingent on interest rate cuts for conversion. This operational momentum is supported by robust historical performance, including a 45.14% revenue growth over the last twelve months and a 41% year-over-year revenue increase in Q1 2025 to $307 million. Looking forward, Morgan Stanley projects a substantial improvement in the firm's compensation ratio from 69% to 63% by 2026, which is expected to fuel a 74% increase in EPS in 2026 over 2025. Strategically, Moelis is launching a new Private Funds Advisory (PFA) division, led by a key hire from Jefferies, to capitalize on long-term demand for continuation funds, signaling a new avenue for growth. While Q1 EPS of $0.64 slightly missed one analyst's estimate, it beat consensus, and the planned CEO succession to Navid Mahmoodzadegan is viewed as a stable transition. Despite this positive outlook, some analysts, like Citizens JMP, maintain a Market Perform rating, citing caution around elevated non-compensation expenses and market uncertainty.

Key Decisions for Investors

• Investors should view the Morgan Stanley upgrade as a significant bullish signal, given it's based on a record deal pipeline, strong forward-looking EPS growth projections, and management confidence that is not reliant on imminent rate cuts.
• The strategic expansion into Private Funds Advisory (PFA) represents a key long-term growth catalyst that should be monitored, while the planned CEO succession appears to provide leadership continuity and stability.
• For income-focused investors, the 4.6% dividend yield, backed by strong cash flow and a 12-year payment history, offers an attractive income component to the potential for capital appreciation.
• It is prudent to remain aware of cautionary notes regarding elevated non-compensation expenses and broader market uncertainty, which could impact the firm's ability to fully convert its strong revenue momentum into bottom-line growth.